Global Enoxaparin Sodium Market Research Report 2023(Status and Outlook)

Global Enoxaparin Sodium Market Research Report 2023(Status and Outlook)

Report Overview

Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein.It is also used during hemodialysis.

Europe is the largest market of Enoxaparin Sodium, with about 60% market share, followed by North America with about 17% market share. Currently, there are many players in this market.Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi, Rovi, Amphastar, Nanjing King-friend, Sandoz and some others are playing important roles in Enoxaparin sodium injection industry. Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi and Rovi are the top 5 players of Enoxaparin Sodium, with about 85% market shares.

There are nine different dosage form of Enoxaparin Sodium. The market can be segmented into 20 mg/0.2mL, 30 mg/0.3mL, 40 mg/0.4mL, 60 mg/0.6mL, 80 mg/0.8mL, 100 mg/1mL, 120 mg/0.8mL, 150 mg/1mL, 300mg/3mL. 40 mg/0.4mL is almost the only used and efficient types and took 40% market share. By application, Hospital is the largest consumer group, with market share of 63%.

The Global Enoxaparin Sodium Market Size was estimated at USD 2906.00 million in 2022 and is projected to reach USD 5078.02 million by 2029, exhibiting a CAGR of 8.30% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Enoxaparin Sodium market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Enoxaparin Sodium Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Enoxaparin Sodium market in any manner.

Global Enoxaparin Sodium Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Sanofi

Teva

Techdow (Hepalink)

Fresenius Kabi

Rovi

Amphastar

Nanjing King-friend

Sandoz

Apotex

Hangzhou Jiuyuan Gene Engineering

Cipla

Taj Pharma

Chengdu Baiyu Pharmaceutical

Suzhou Erye Pharmaceutical

Changzhou Qianhong Bio-pharma

Hebei Changshan Biochemical Pharmaceutical

Beijing SL Pharmaceutical

Huadong Medicine

Bharat Serums

INTAS

LUPIN

Troikaa Pharmaceuticals

Aristopharma

Fosun Pharma

SciencePharma

PISA

Market Segmentation (by Type)

20 mg/0.2mL

30 mg/0.3mL

40 mg/0.4mL

60 mg/0.6mL

80 mg/0.8mL

100 mg/1mL

120 mg/0.8mL

150 mg/1mL

300mg/3mL

Market Segmentation (by Application)

Commercial

Industrial

Public

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Enoxaparin Sodium Market

Overview of the regional outlook of the Enoxaparin Sodium Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors